Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

Objective To characterise the clinical features of monkeypox infection in humans. Design
Descriptive case series. Setting A regional high consequences infectious disease centre with …

Background Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone
of SARS-CoV-2 mass community testing, although their reduced sensitivity compared …

There is a clear requirement for an accurate SARS-CoV-2 antibody test, both as a complement
to existing diagnostic capabilities and for determining community seroprevalence. We …

2. World Health Organization (WHO). WHO Director-General's opening remarks at the media
briefing on COVID-19-11 March 2020. Available at: https://www. who. int/dg/speeches/detail …

Background The need for a fast and reliable test for COVID-19 is paramount in managing the
current pandemic. A cost effective and efficient diagnostic tool as near to the point of care (…

Introduction Antibodies to SARS-CoV-2 serve as critical diagnostic markers for determining
how broadly the COVID-19 pandemic has spread, confirming patient recovery, monitoring …

Background: To date, although neonatal infections with severe acute respiratory syndrome
coronovirus 2 (SARS-CoV-2) have been described, none of these have been proven to be …

Background : Viral diversity presents an ongoing challenge for diagnostic tests, which need
to accurately detect all circulating variants. The Abbott Global Surveillance program monitors …